Amendment 162
Framework for strengthening the availability and security of supply of critical medicinal products as well as the availability of, and accessibility of, medicinal products of common interest
A10-0272/2025 – Tomislav Sokol – Amendments by the committee responsible – separate vote – Am 162
Adopted
- For
- 494
- Against
- 152
- Abstained
- 17
roll-call vote at 12:44 · 75% of votes cast in favour
Roll call requested by Patriots
How the groups voted
A group’s line is the position at least two thirds of its voting MEPs took; otherwise it is shown as Divided. Groups from left to right.
| Group | For | Against | Abstained | of | Line |
|---|---|---|---|---|---|
| The Left | 38 | 1 | 0 | 39 | For |
| Greens | 51 | 0 | 0 | 51 | For |
| S&D | 122 | 0 | 2 | 124 | For |
| Renew | 54 | 8 | 6 | 68 | For |
| EPP | 157 | 23 | 0 | 180 | For |
| ECR | 59 | 13 | 0 | 72 | For |
| Patriots | 0 | 79 | 0 | 79 | Against |
| ESN | 0 | 24 | 0 | 24 | Against |
| No group | 13 | 4 | 9 | 26 | — |
“of” = MEPs of the group who voted. Groups as they are now.
Every MEP
24 MEPs of 663 Clear filters
“Votes in which an MEP voted differently from their group: on decision pages, against a line at least two thirds of the group took; in loyalty figures, against the position most of the group took.” = voted otherwise than a clear line (two thirds of its votes) of the group they sit in now. MEPs with no vote recorded are not listed.